title: Recurring cutaneous eruption in a patient with metastatic renal cell carcinoma being treated with high-dose interleukin 2.
authors.affiliation: Dermatology Branch, National Cancer Institute, Bethesda, MD 20892-1908, USA.
authors.forename: Fiona
authors.initials: F
authors.lastname: O'Reilly
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Feldman
authors.forename: James
authors.initials: J
authors.lastname: Yang
authors.forename: Patrick
authors.initials: P
authors.lastname: Hwu
authors.forename: Maria L
authors.initials: ML
authors.lastname: Turner
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001706:Biopsy; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary*; D003875:Drug Eruptions / Q000209:etiology / Q000473:pathology*; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D012008:Recurrence; D012867:Skin / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D007376:Interleukin-2; D011994:Recombinant Proteins